Global Allogeneic Stem Cell Therapies Competitive Landscape Professional Research Report 2024

Research Summary

Allogeneic cell therapies refer to treatments that use cells from a donor other than the recipient. These cells can be derived from various sources, including bone marrow, umbilical cord blood, and peripheral blood. The goal of allogeneic cell therapies is to harness the properties of these cells to treat a range of diseases and conditions, such as cancer, autoimmune disorders, and genetic diseases. In many cases, these therapies involve modifying the donor cells to enhance their therapeutic potential or to reduce the risk of rejection by the recipient's immune system.

According to DIResearch's in-depth investigation and research, the global Allogeneic Stem Cell Therapies market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Allogeneic Stem Cell Therapies include Escape Therapeutics, Inc., Lonza Group Ltd., Osiris Therapeutics (Smith & Nephew), NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Anterogen, MolMed S.p.A., Takeda (TiGenix) etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Allogeneic Stem Cell Therapies. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Allogeneic Stem Cell Therapies market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Allogeneic Stem Cell Therapies market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Allogeneic Stem Cell Therapies industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Allogeneic Stem Cell Therapies Include:

Escape Therapeutics, Inc.

Lonza Group Ltd.

Osiris Therapeutics (Smith & Nephew)

NuVasive

Chiesi Pharmaceuticals

JCR Pharmaceutical

Pharmicell

Anterogen

MolMed S.p.A.

Takeda (TiGenix)

Allogeneic Stem Cell Therapies Product Segment Include:

Adult Stem Cell Therapy

Human Embryonic Stem Cell Therapy

Induced Pluripotent Stem Cell Therapy

Others

Allogeneic Stem Cell Therapies Product Application Include:

Musculoskeletal Disorder

Wounds & Injuries

Cardiovascular Diseases

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Allogeneic Stem Cell Therapies Industry PESTEL Analysis

Chapter 3: Global Allogeneic Stem Cell Therapies Industry Porter's Five Forces Analysis

Chapter 4: Global Allogeneic Stem Cell Therapies Major Regional Market Size and Forecast Analysis

Chapter 5: Global Allogeneic Stem Cell Therapies Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Allogeneic Stem Cell Therapies Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Allogeneic Stem Cell Therapies Market Overview

1.1 Product Definition and Statistical Scope

1.2 Allogeneic Stem Cell Therapies Product by Type

1.2.1 Global Allogeneic Stem Cell Therapies Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Adult Stem Cell Therapy

1.2.3 Human Embryonic Stem Cell Therapy

1.2.4 Induced Pluripotent Stem Cell Therapy

1.2.5 Others

1.3 Allogeneic Stem Cell Therapies Product by Application

1.3.1 Global Allogeneic Stem Cell Therapies Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Musculoskeletal Disorder

1.3.3 Wounds & Injuries

1.3.4 Cardiovascular Diseases

1.3.5 Others

1.4 Global Allogeneic Stem Cell Therapies Market Revenue Analysis (2019-2030)

1.5 Allogeneic Stem Cell Therapies Market Development Status and Trends

1.5.1 Allogeneic Stem Cell Therapies Industry Development Status Analysis

1.5.2 Allogeneic Stem Cell Therapies Industry Development Trends Analysis

2 Allogeneic Stem Cell Therapies Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Allogeneic Stem Cell Therapies Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Allogeneic Stem Cell Therapies Market Analysis by Regions

4.1 Allogeneic Stem Cell Therapies Overall Market: 2023 VS 2024 VS 2030

4.2 Global Allogeneic Stem Cell Therapies Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Allogeneic Stem Cell Therapies Revenue and Market Share by Region (2019-2024)

4.2.2 Global Allogeneic Stem Cell Therapies Revenue Forecast by Region (2025-2030)

5 Global Allogeneic Stem Cell Therapies Market Size by Type and Application

5.1 Global Allogeneic Stem Cell Therapies Market Size by Type

5.2 Global Allogeneic Stem Cell Therapies Market Size by Application

6 North America

6.1 North America Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Allogeneic Stem Cell Therapies Market Size by Type

6.4 North America Allogeneic Stem Cell Therapies Market Size by Application

6.5 North America Allogeneic Stem Cell Therapies Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Allogeneic Stem Cell Therapies Market Size by Type

7.4 Europe Allogeneic Stem Cell Therapies Market Size by Application

7.5 Europe Allogeneic Stem Cell Therapies Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Allogeneic Stem Cell Therapies Market Size by Type

8.4 China Allogeneic Stem Cell Therapies Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Allogeneic Stem Cell Therapies Market Size by Type

9.4 APAC (excl. China) Allogeneic Stem Cell Therapies Market Size by Application

9.5 APAC (excl. China) Allogeneic Stem Cell Therapies Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Allogeneic Stem Cell Therapies Market Size by Type

10.4 Latin America Allogeneic Stem Cell Therapies Market Size by Application

10.5 Latin America Allogeneic Stem Cell Therapies Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Allogeneic Stem Cell Therapies Market Size by Type

11.4 Middle East & Africa Allogeneic Stem Cell Therapies Market Size by Application

11.5 Middle East & Africa Allogeneic Stem Cell Therapies Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Allogeneic Stem Cell Therapies Market Revenue by Key Manufacturers (2020-2024)

12.2 Allogeneic Stem Cell Therapies Competitive Landscape Analysis and Market Dynamic

12.2.1 Allogeneic Stem Cell Therapies Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Escape Therapeutics, Inc.

13.1.1 Escape Therapeutics, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapies Product Portfolio

13.1.3 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Lonza Group Ltd.

13.2.1 Lonza Group Ltd. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Lonza Group Ltd. Allogeneic Stem Cell Therapies Product Portfolio

13.2.3 Lonza Group Ltd. Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Osiris Therapeutics (Smith & Nephew)

13.3.1 Osiris Therapeutics (Smith & Nephew) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapies Product Portfolio

13.3.3 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 NuVasive

13.4.1 NuVasive Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 NuVasive Allogeneic Stem Cell Therapies Product Portfolio

13.4.3 NuVasive Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Chiesi Pharmaceuticals

13.5.1 Chiesi Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapies Product Portfolio

13.5.3 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 JCR Pharmaceutical

13.6.1 JCR Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 JCR Pharmaceutical Allogeneic Stem Cell Therapies Product Portfolio

13.6.3 JCR Pharmaceutical Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Pharmicell

13.7.1 Pharmicell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Pharmicell Allogeneic Stem Cell Therapies Product Portfolio

13.7.3 Pharmicell Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Anterogen

13.8.1 Anterogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Anterogen Allogeneic Stem Cell Therapies Product Portfolio

13.8.3 Anterogen Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 MolMed S.p.A.

13.9.1 MolMed S.p.A. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 MolMed S.p.A. Allogeneic Stem Cell Therapies Product Portfolio

13.9.3 MolMed S.p.A. Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Takeda (TiGenix)

13.10.1 Takeda (TiGenix) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Takeda (TiGenix) Allogeneic Stem Cell Therapies Product Portfolio

13.10.3 Takeda (TiGenix) Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Allogeneic Stem Cell Therapies Industry Chain Analysis

14.2 Allogeneic Stem Cell Therapies Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Allogeneic Stem Cell Therapies Typical Downstream Customers

14.4 Allogeneic Stem Cell Therapies Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support